Advanced Medical Solutions Group (AMS) Stock Overview
Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 1/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
AMS Community Fair Values
See what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.
Advanced Medical Solutions Group plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£2.06 |
52 Week High | UK£2.76 |
52 Week Low | UK£1.68 |
Beta | 0.78 |
1 Month Change | -3.74% |
3 Month Change | 15.73% |
1 Year Change | -9.65% |
3 Year Change | -28.35% |
5 Year Change | -6.15% |
Change since IPO | 67.48% |
Recent News & Updates
Recent updates
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Advanced Medical Solutions Group plc's (LON:AMS) CEO For Now
Jun 23What You Can Learn From Advanced Medical Solutions Group plc's (LON:AMS) P/E After Its 25% Share Price Crash
Apr 27There May Be Some Bright Spots In Advanced Medical Solutions Group's (LON:AMS) Earnings
Mar 28Investors Could Be Concerned With Advanced Medical Solutions Group's (LON:AMS) Returns On Capital
Jan 15Advanced Medical Solutions Group plc's (LON:AMS) Popularity With Investors Is Under Threat From Overpricing
Nov 18A Look At The Fair Value Of Advanced Medical Solutions Group plc (LON:AMS)
Sep 07Should You Be Adding Advanced Medical Solutions Group (LON:AMS) To Your Watchlist Today?
Nov 03Advanced Medical Solutions Group plc (LON:AMS) Shares Could Be 38% Below Their Intrinsic Value Estimate
Sep 05Advanced Medical Solutions Group (LON:AMS) Will Want To Turn Around Its Return Trends
Dec 03Are Investors Undervaluing Advanced Medical Solutions Group plc (LON:AMS) By 23%?
Sep 03Advanced Medical Solutions Group's (LON:AMS) Returns On Capital Not Reflecting Well On The Business
Aug 05An Intrinsic Calculation For Advanced Medical Solutions Group plc (LON:AMS) Suggests It's 33% Undervalued
May 31Advanced Medical Solutions Group (LON:AMS) May Have Issues Allocating Its Capital
Apr 23Advanced Medical Solutions Group (LON:AMS) Might Be Having Difficulty Using Its Capital Effectively
Jan 08A Look At The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Nov 24Some Investors May Be Worried About Advanced Medical Solutions Group's (LON:AMS) Returns On Capital
May 22A Look At The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Apr 10Results: Advanced Medical Solutions Group plc Exceeded Expectations And The Consensus Has Updated Its Estimates
Mar 20Should Advanced Medical Solutions Group (LON:AMS) Be Disappointed With Their 30% Profit?
Feb 28The Returns At Advanced Medical Solutions Group (LON:AMS) Provide Us With Signs Of What's To Come
Feb 07Advanced Medical Solutions Group plc's (LON:AMS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jan 18Shareholder Returns
AMS | GB Medical Equipment | GB Market | |
---|---|---|---|
7D | -1.9% | -3.3% | 0.4% |
1Y | -9.6% | 3.3% | 4.8% |
Return vs Industry: AMS underperformed the UK Medical Equipment industry which returned 3.3% over the past year.
Return vs Market: AMS underperformed the UK Market which returned 4.8% over the past year.
Price Volatility
AMS volatility | |
---|---|
AMS Average Weekly Movement | 6.3% |
Medical Equipment Industry Average Movement | 6.7% |
Market Average Movement | 5.3% |
10% most volatile stocks in GB Market | 11.6% |
10% least volatile stocks in GB Market | 3.0% |
Stable Share Price: AMS has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: AMS's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1991 | 1,600 | Chris Meredith | www.admedsol.com |
Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. The company operates in two segments, Surgical and Woundcare. It offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, infection control, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G, Vitalitec, and ActivHeal brand names.
Advanced Medical Solutions Group plc Fundamentals Summary
AMS fundamental statistics | |
---|---|
Market cap | UK£444.34m |
Earnings (TTM) | UK£7.09m |
Revenue (TTM) | UK£177.52m |
Is AMS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AMS income statement (TTM) | |
---|---|
Revenue | UK£177.52m |
Cost of Revenue | UK£84.90m |
Gross Profit | UK£92.62m |
Other Expenses | UK£85.52m |
Earnings | UK£7.09m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.033 |
Gross Margin | 52.17% |
Net Profit Margin | 4.00% |
Debt/Equity Ratio | 30.2% |
How did AMS perform over the long term?
See historical performance and comparisonDividends
Does AMS pay a reliable dividends?
See AMS dividend history and benchmarksAdvanced Medical Solutions Group dividend dates | |
---|---|
Ex Dividend Date | Jun 19 2025 |
Dividend Pay Date | Jul 17 2025 |
Days until Ex dividend | 20 days |
Days until Dividend pay date | 8 days |
Does AMS pay a reliable dividends?
See AMS dividend history and benchmarksCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/07/08 03:34 |
End of Day Share Price | 2025/07/08 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Advanced Medical Solutions Group plc is covered by 21 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Samuel England | Berenberg |
Julie Simmonds | Canaccord Genuity |
Keith Redpath | Cavendish |